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Abstract
Cognitive remediation is a promising pathway for ameliorating cognitive impairment of patients with schizophrenia.
Here, we investigate predictors of improvement in problem-solving ability for two different types of cognitive remediation –
specific problem-solving training and training of basic cognition. For this purpose we conducted a re-analysis of a randomized
controlled trial comparing these two training approaches. The main outcome measure was improvement in problem-solving
performance. Correlational analyses were used to assess the contribution of clinical, cognitive and training-related predictors.
In the problem-solving training group, impaired pre-training planning ability was associated with stronger improvement. In
contrast, in the basic cognition training group antipsychotic medication dose emerged as a negative predictor. These results
demonstrate that predictors for successful cognitive remediation depend on the specific intervention. Furthermore, our results
suggest that at least in the planning domain patients with impaired performance benefit particularly from a specific
intervention. (JINS, 2014, 20, 455–460)
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INTRODUCTION
Cognitive impairment is a core feature of schizophrenia, and
essentially all cognitive domains are frequently impaired in
schizophrenia (Heinrichs & Zakzanis, 1998). Moreover,
cognitive deficits are strongly associated with lower levels of
psychosocial functioning (Bowie et al., 2010). Consequently,
several psychological treatment strategies have been
developed to improve cognitive function and are now
subsumed under the term cognitive remediation (McGurk,
Twamley, Sitzer, McHugo, & Mueser, 2007; Wykes, Huddy,
Cellard, McGurk, & Czobor, 2011). Cognitive remediation
has been shown to improve cognition and can generalize to
functional outcome, particularly when cognitive remediation
is combined with comprehensive rehabilitation.
Although there is considerable evidence for the efficacy of
cognitive remediation in schizophrenia, little is known about
potential predictors of a favorable treatment response. The few
studies conducted vary considerably in outcome measures
and training interventions. Overall, there is some evidence that
even severe cognitive impairment at baseline does not preclude
gains through cognitive remediation (Medalia & Richardson,
2005). A recent study has even reported stronger improvement
for patients with lower baseline cognitive performance and
symptom severity during a compensatory cognitive training
intervention (Twamley, Burton, & Vella, 2011). In contrast,
other studies suggest that baseline attention, working memory,
and executive function deficits might limit the gains from
cognitive remediation (Fiszdon, Cardenas, Bryson, & Bell,
2005; Kurtz, Seltzer, Fujimoto, Shagan, & Wexler, 2009;
Vita et al., 2013). Other authors have argued that intrinsic
motivation and treatment adherence might play a more
important role for treatment success than cognitive variables
(Medalia & Saperstein, 2011). In an important recent study,
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Vita and colleagues have emphasized the potential negative
predictive value of antipsychotic dose at baseline (Vita et al.,
2013). Finally, shorter illness duration and younger age have
been reported to be associated with stronger improvement
during cognitive remediation (Bowie, Grossman, Gupta,
Oyewumi, & Harvey, 2014; Kontis, Huddy, Reeder, Landau,
& Wykes, 2013). All of these authors have highlighted the need
for future studies to address the question which patient is
most likely to benefit from cognitive remediation. Importantly,
it is unknown whether different variables predict success of
different types of remediation interventions, in particular when
different cognitive constructs are addressed through training.
We address this question using data from a randomized
controlled trial examining the effects of problem-solving
training versus training of basic cognition (Rodewald et al.,
2011). In this trial strong differential effects were observed
on problem-solving capacity as assessed with Plan-a-Day,
a new instrument to assess complex planning and
problem-solving ability. This is of particular relevance, because
Plan-a-Day emulates real-world situations and Plan-a-Day
performance has been shown to be a good predictor of global
functioning (Holt et al., 2011). In the present study, we
asked which baseline variables predict improvement of
problem-solving ability as assessed by Plan-a-Day in response
to either a specific problem-solving training or a general
training of basic cognition.
METHODS
Clinical Trial Design
We carried out a single-blind randomized trial comparing a
training of planning and problem-solving ability (PLAN)
against basic cognitive training. All participants received
training interventions and a 3-week course of inpatient work
therapy at an inpatient rehabilitation clinic. Patients fulfilled
DSM-IV criteria for schizophrenia or schizoaffective
disorder as confirmed by the MINI International
Neuropsychiatric Interview. Further inclusion criteria were
(1) age between 18 and 45, (2) being in a non-acute phase of
illness (defined by all PANSS positive items ,5), and
(3) having an estimated IQ of 80 or above. Exclusion criteria
were (1) diagnosis of a neurological disorder, (2) illicit
substance use during the last month, and (3) a current
comorbid Axis-I disorder.
Patients (n5 77) engaged in 10 training sessions of
computer-based cognitive exercises over 3 weeks either
targeting planning and problem-solving or basic cognition.
Average treatment attendance was 8.4 of 10 sessions.
Both training regimes were implemented with the RehaCom
Software Package (Hasomed GmbH, Germany). Each
session lasted 45 min and took place in small groups.
The experimental group trained planning and problem-
solving via PLAN, a training concept that was originally
developed by Funke and Kru¨ger (1995). It focuses on training
participants to use a small set of simple but effective planning
and decision-making heuristics (e.g., ‘‘most important tasks
always first’’ or ‘‘maximize number or errands completed’’)
that provide effective strategies for dealing with common
goal-conflict situations in Plan-a-Day and everyday life.
The basic cognition group trained three different tasks:
processing speed, attention/concentration and topological
memory.
A more detailed description of the study design has been
published in another study that describes a differential
improvement in functional outcome based on two different
cognitive trainings (Rodewald et al., 2011). The study was
approved by the local ethics committee and all participants
provided written informed consent. The clinical trial
registration number is NCT00507988 (clinicaltrials.gov).
Criterion Variable: Problem-solving Ability
Planning and problem-solving ability in a complex
real-world scenario was measured with the Plan-a-Day test.
The Plan-a-Day test and the PLAN training are both based
on a daily errands scheduling paradigm, but differ in
user interface, task sets, available operators, and solution
strategies required. We have previously shown that
the Plan-A-Day test accounts for more variance in the Global
Assessment of Functioning than other planning tests
(Holt et al., 2011).
Predictors: Cognitive Functions
The following cognitive functions were assessed: working
memory maintenance: digit span forward (Von Aster,
Neubauer, & Horn, 2006), corsi block tapping forward
(Schellig, 1993); working memory manipulation: digit span
backward (Von Aster et al., 2006), letter-number-sequencing
(Von Aster et al., 2006), corsi block tapping backward
(Schellig, 1993); processing speed: Trail Making Test
A (Reitan, 1992), Stroop neutral condition (color naming)
(Markela-Lerenc, Kaiser, Fiedler, Weisbrod, & Mundt, 2006),
shifting: Trail Making Test B (Reitan, 1992), Stroop incon-
gruent condition (Markela-Lerenc et al., 2006), planning:
Zoo-Map (Ufer, 2000), planning test (Kohler & Beck, 2004)
and premorbid intelligence: multiple choice vocabulary test—
MWT-B (Lehrl, 2005). Scores were Z-transformed and
summarized for the above described domains.
Predictors: Clinical Variables
Symptoms were assessed by trained research psychologists
using the Positive and Negative Syndrome Scale – PANSS.
We used the consensus factor model proposed by Wallwork,
Fortgang, Hashimoto, Weinberger, and Dickinson, (2012).
All patients were treated with atypical antipsychotic
medication. Medication dosage was transformed to
chlorpromazine equivalents (Andreasen, Pressler, Nopoulos,
Miller, & Ho, 2010).
Predictors: Training Variables
The number of attended training sessions was recorded.
Furthermore, for the PLAN training group we extracted
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the participant’s progress through the training program.
Finally, participants filled out a questionnaire to assess task
motivation at the end of the training (Rheinberg, Vollmeyer,
& Burns, 2001). We summarized the questionnaires’
subscales ‘‘interest,’’ ‘‘challenge,’’ and ‘‘probability of
success,’’ because they best reflect the construct of intrinsic
motivation.
Statistical Analysis
We calculated Pearson correlations between potential
predictors at baseline and change in problem-solving
capacity pre-/post-training separately for both training
groups. Cognitive and clinical variables at baseline as well as
training related variables were regarded as potential
predictors (see Table 2 for overview). We used SPSS Version
16 for statistical analyses. All statistical tests were two-tailed,
and significance was determined as p, .05.
RESULTS
Comparison of Both Groups at Baseline
The training groups did not show significant differences for
demographic and symptom variables (see Table 1). However,
antipsychotic dose was higher in the basic cognitive training
group.
Change in Problem-Solving Ability
The main focus of the original study was a differential effect
of two training interventions on cognition and functional
capacity. As reported by Rodewald and colleagues, both
groups improved on measures of cognitive functioning and
functional capacity (Rodewald et al., 2011). The planning
and problem-solving training led to stronger improvement on
Plan-a-Day solution time (see Table 1). In an exploratory
analysis, we found a significant time by group interaction
for reaction time in the neutral condition (color naming) of
the Stroop test (F[1,69]5 8.22; p, .01), suggesting an
advantage for basic cognitive training.
Correlational Analysis within the Problem-Solving
Training Group
An overview of the correlational analyses is given in Table 2.
Pearson correlations yielded a significant relationship only
between the change in problem-solving ability and
pre-training planning ability, that is, the summarized Z-score
for solution time in the Tower of London analogue and the
Zoo-map task. In other words patients who were most
impaired in the planning domain showed the strongest benefit
from a domain specific training. No other cognitive, clinical
(including antipsychotic dose) or training variable was
significantly correlated with change in problem-solving
ability.
Correlational Analysis within the Basic Cognition
Training Group
In the basic cognition training group only the medication
dosage in chlorpromazine equivalents was significantly cor-
related with change in problem-solving ability, indicating
less improvement with higher baseline antipsychotic dose
(see Table 2). No significant correlations were found between
change in problem-solving ability and any other demo-
graphic, cognitive (including pre-training planning ability) or
clinical variable.
Table 1. Baseline characteristics of training group and change in problem-solving
Problem-solving training (n5 38) Basic cognition training (n5 37) Test statistic
Demographics
Age 28.0 (7.0) 29.5 (7.4) t520.87
Gender male 32 (84%) 30 (77%) w25 0.65
Years of education 14.7 (2.9) 15.6 (3.7) t521.13
Clinical variables
PANSS total score1 62.0 (8.7) 63.8 (12.5) t520.72
PANSS positive 1.5 (0.5) 1.8 (0.6) t5 0.04
PANSS negative 2.6 (0.7) 2.6 (0.7) t521.47
PANSS disorganized 2.6 (0.7) 2.6 (0.7) t5 0.04
PANSS excited 1.5 (0.4) 1.6 (0.4) t520.55
PANSS depressed 2.3 (0.8) 2.5 (0.8) t520.85
Duration of illness 5.0 (4.5) 3.8 (3.1) t5 1.39
Chlorpromazine equivalents 325.1 (206.0) 475.3 (266.3) t5 2.36*
Outcome: problem-solving
Solution time pre-training 106.9 (42.4) 84.0 (38.0) Finteraction
Solution time post-training 63.4 (22.5) 74.2 (38.9) 521.95**
1For the Positive and Negative Syndrome Scale (PANSS) the sum of all item scores is given. In contrast, for factor scores average item
scores are given to provide a more intuitive grading of symptom severity.
*p, .05, **p, .001.
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To assess whether antipsychotic dose was related to
clinical or cognitive variables we calculated correlations with
all PANSS factor scores and all cognitive domain scores at
baseline. Antipsychotic dose was not significantly correlated
with any of these variables including processing speed
(all p. .1).
DISCUSSION
The present study shows that the predictors of improvement
in problem-solving ability during cognitive remediation
depend on the type of remediation program used. When
patients trained planning and problem-solving, their
improvement in this domain was predicted only by planning
ability at baseline. Planning impairment was associated with
stronger benefit from specific problem-solving training.
In contrast, for the basic cognition training improvement
of problem-solving ability was negatively predicted by
antipsychotic medication dosage. This dissociation of
predictors indicates that the predictive effect of planning
ability at baseline does not merely reflect regression to
the mean. Instead, it suggests a genuine interaction of
baseline variables and the type of remediation treatment.
These findings have several implications.
First, our findings suggest that—in the planning domain—
patients benefit from training a specific cognitive function
that has been identified as impaired. This relates to an
ongoing discussion about the optimal strategy for cognitive
remediation regarding whether one should specifically
attempt to improve impaired functions (Silverstein &
Wilkniss, 2004). An important recent trial suggests that there
might be little difference between a generic approach and
remediation targeted toward areas of individual impairment
(Franck et al., 2013). While there are considerable differences
between studies, our findings suggest that for the domain of
planning and problem-solving an individualized approach
specifically targeting this impairment could be of value.
Second, considering that both training forms were of
comparable effectiveness (Rodewald et al., 2011), the
presence of training-specific moderator variables suggests
different neurocognitive mechanisms underlying the training
gains. Since the planning and problem-solving training is
largely a cognitive strategy training, it may be particularly
suited to compensate specific strategy deficits as reflected in
baseline planning ability. In contrast, the basic cognition
training is more strongly aimed at enhancing basic cognitive
capacity independent of specific strategies.
Third, in the basic cognition group, improvement on
planning and problem-solving was dependent on baseline
antipsychotic dose. This association of cognitive remediation
effects with antipsychotic dose is a recent finding and has to
our knowledge only been reported in a recent study by
Vita and colleagues (2013). This study found a negative
impact of higher baseline antipsychotic dose for both training
programs used. However, a direct comparison between
studies is difficult, because of major differences in the
interventions. In line with Vita et al., we propose two possible
reasons for the negative impact of antipsychotic dose on
treatment success. First, higher antipsychotic dose could
characterize more severely impaired patients, but neither the
Vita study nor our own study provides any direct evidence for
this assumption. In our study antipsychotic dose was
not related to clinical or cognitive variables at baseline.
Second, antipsychotic medication could have a negative
Table 2. Correlations between change in problem-solving capacity and cognitive, clinical and training variables
Change in problem-solving ability
Problem-solving training Basic cognition training
Cognitive variables
Planning 0.38* 20.04
Working memory maintenance 0.02 0.12
Working memory manipulation 0.04 0.05
Processing speed 0.09 20.25
Shifting/Inhibition 20.12 0.04
Clinical variables
PANSS positive factor 0.08 20.11
PANSS negative factor 0.04 0.09
PANSS disorganized factor 0.04 0.09
PANSS excited factor 20.03 0.08
PANSS depressed factor 20.23 0.24
Duration of illness 0.21 20.06
Chlorpromazine equivalents 20.01 20.35*
Training variables
Attended training sessions 0.15 0.07
Training progress 0.15 n.a.
Task motivation 0.12 0.12
*p, .05.
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impact on learning processes required for successful
remediation. Preclinical and clinical studies have long
suggested a negative effect of dopamine antagonists on
incentive and reinforcement learning (Cutmore & Beninger,
1990; Ettenberg, 1989). This might be particularly relevant in
our basic cognitive training, in which learning from positive
feedback is essential for improving performance.
In addition to the observed predictors, it is also important
to briefly address the variables not found to predict
improvement during training. We did not find any
relationship between baseline symptoms and improvement
during training, which is in line with previous reports (Kurtz
et al., 2009). We were particularly interested in the effects of
motivation as its role has been recently emphasized in the
literature (Medalia & Saperstein, 2011). However, we did not
find an effect of negative symptoms or intrinsic motivation,
which capture different aspects of motivation. Furthermore,
in contrast to previous reports the number of attended
training sessions did not predict improvement (Medalia &
Richardson, 2005). The missing effect of motivation and
attendance is most likely related to the fact that our study was
conducted in an inpatient rehabilitation setting with high
treatment adherence (Scheu et al., 2013).
The current study has some important limitations. First, the
cognitive and functional impairments in our patient sample
were not as severe as in some previous studies, which might
limit generalizability of the findings. Second, our remediation
program was short in comparison with most current studies
and focused on a narrower range of cognitive functions.
However, meta-analyses have suggested that even short
interventions are effective (McGurk et al., 2007; Wykes
et al., 2011). Nevertheless, it is an open question whether
our findings can apply to longer, more comprehensive
interventions. Third, randomization resulted in a higher
antipsychotic dose at baseline in the basic cognitive training
group, which could contribute to its differential predictive
power in this group. Finally, the study was conducted in an
inpatient rehabilitation program, which limits generalization
to less structured outpatient treatment settings.
Overall, the present study shows that improvement in
problem-solving ability is differentially predicted depending
on the training program used. In the problem-solving group,
the most impaired patients in this domain showed the
strongest benefit. In contrast, in the basic cognition training
group remediation success was predicted by antipsychotic
dosing. To our knowledge, this is the first study to show that
the predictors of remediation success strongly depend on the
remediation program used. Although the present study is
focused on two specific interventions in a restricted setting,
our findings have clear implications for further research.
Predictors of cognitive remediation will have to be found
specifically for each type of training program to allow for an
optimal individualization of treatment. Furthermore,
regarding the development of individualized cognitive
remediation our results suggest that at least in the
planning domain patients with impaired performance benefit
particularly from a specific intervention.
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